Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)

Clinical trial NCT06222034 · TERMINATED

Trial details

NCT number: NCT06222034
Sponsor: Alfasigma S.p.A.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Juvenile Idiopathic Arthritis

Start date: 2024-05-13
Primary completion: 2026-06-17
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.